Propanc Biopharma Inc — Financial Statements (NASDAQ:PPCB)

Financials

Total revenue 0000-960.28 K -32.06 K Gross profit 0000-960.28 K -32.06 K Operating expenses 1.81 M1.99 M1.78 M1.54 M57.28 M 65.1 M Selling/general/admin expenses 1.55 M1.71 M1.5 M1.25 M57.03 M 64.88 M Research & development 230.96 K256.05 K247.92 K248.1 K223.72 K 187.78 K Operating income -1.81 M-1.99 M-1.78 M-1.54 M-57.28 M -65.1 M Non-Operating Income, Total -327.22 K-722.19 K-1.01 M-413.61 K-1.65 M -965.68 K Interest expense, net of interest capitalized 449.46 K568.8 K532.82 K665.84 K563.76 K 723.19 K Non-Operating Income, excl. Interest Expenses -776.68 K-1.29 M-1.55 M-1.08 M-2.21 M -1.63 M Unusual income/expense ————— — Pretax income -2.14 M-2.71 M-2.79 M-1.95 M-58.92 M -66.07 M Equity in earnings ————— — Taxes -113.41 K-54.98 K-129.84 K-129.13 K0 0 Non-controlling/minority interest ————— — After tax other income/expense -16.5 K-2 250-1 838-3 832-5 519 -6 780 Net income before discontinued operations -2.42 M-2.66 M-2.66 M-1.82 M-58.92 M -66.07 M Discontinued operations ————— — Net income -2.42 M-2.66 M-2.66 M-1.82 M-58.92 M -66.07 M Dilution adjustment —0000 — Preferred dividends —700.34 K466.27 K192.96 K0 — Diluted net income available to common stockholders -2.42 M-3.36 M-3.13 M-2.01 M-58.92 M -67 M Basic earnings per share (Basic EPS) —-3 M-108 K-1 200-14.85 52.11 Diluted earnings per share (Diluted EPS) —-2.34 M-108 K-1 200-14.85 52.11 Average basic shares outstanding —1.1428.981 417.423.97 M 33.47 M Diluted shares outstanding —1.1428.981 417.423.97 M 33.47 M EBITDA ————— — EBIT ————— — Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 218.4 K527.8 K313.45 K383.91 K46.2 K 87.65 K